Antrogen, Active Community... Stock Price 0.0%.
At this time, posts about Antrogen are rapidly increasing on portals and stock communities, while foreign investors are tentatively reported to have net purchased 306 shares today. Antrogen is known as a company that develops and sells stem cell therapeutics.
As of 11:30 AM on the 29th, Antrogen's stock price remains unchanged from the previous day at 63,400 KRW, with a trading volume of 261,471 shares, which is 17.89% of the 5-day average trading volume. On May 21, Antrogen became a market issue with the headline "Antrogen surges for the second day following FDA approval of diabetic foot ulcer treatment."
In addition to Antrogen, posts from investors are also rapidly increasing for Daewoong Pharmaceutical (069620), Blossom M&C (263920), and A-Root (096690).

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.